Home > Insider Trading > Filing (0001144204-12-023548)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1365216	Sucampo Pharmaceuticals Inc.	SCMP	Pharmaceutical Preparations (2834)	133929237

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1472322	Nantahala Capital Management, Llc	100 First Stamford Place 2Nd Floor Stamford CT 06902		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2012-04-23	61,891	$8.25	275,640	No	4	S	Indirect	By Nantahala Capital Partners LP
Class A Common Stock	Disposition	2012-04-23	124,389	$8.25	371,662	No	4	S	Indirect	By Blackwell Partners, LLC
Class A Common Stock	Disposition	2012-04-23	33,620	$8.25	97,788	No	4	S	Indirect	By Silver Creek C.S. SAV, L.L.C.
Class A Common Stock	Disposition	2012-04-23	0	$8.25	438,234	No	4	S	Indirect	By Nantahala Capital Partners II LP
Class A Common Stock	Disposition	2012-04-23	0	$8.25	231,037	No	4	S	Indirect	By Nantahala Capital Partners CL LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Nantahala Capital Partners LP
No	4	S	Indirect	By Blackwell Partners, LLC
No	4	S	Indirect	By Silver Creek C.S. SAV, L.L.C.
No	4	S	Indirect	By Nantahala Capital Partners II LP
No	4	S	Indirect	By Nantahala Capital Partners CL LP

Footnotes

The Reporting Person may be deemed to have indirect beneficial ownership of the reported securities by virtue of its position as the investment manager or general partner for the specified direct owners. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for the purpose of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.